SP-MHCI-0460-3
The Human Gamma-interferon-inducible lysosomal thiol reductase Peptide (IEDB: 37182) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Gamma-interferon-inducible lysosomal thiol reductase Peptide, H-LLDVPTAAV-OH (Uniprot: P13284 aa: 16-24) from JPT is produced under strict quality control and quality management.
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References:
Read References with JPT’s Antigen Peptides
Human Gamma-interferon-inducible lysosomal thiol reductase 16-24, LLDVPTAAV has been described in:
Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers., J Immunol, 2005 (PMID: 16034111)
Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens., Eur J Immunol, 2002 (PMID: 11782012)
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma., Immunity, 2021 (PMID: 34270940)
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Breast cancer, Hepatocellular carcinoma, Leukemia, Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Gamma-interferon-inducible lysosomal thiol reductase |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Information | Values |
---|---|
Sequence: | H-LLDVPTAAV-OH |
Specifications: | 9mer peptide as TFA salt |
Check our list of products, click and go.
Get a quote